Trinity Biotech plc (TRIB) |
|
1.99 -0.02 (-1%)
|
10-01 15:41 |
|
Open: |
2 |
Pre. Close: |
2.01 |
|
High:
|
2.0625 |
Low:
|
1.96 |
|
Volume:
|
216,955 |
Market Cap:
|
42M |
|
|
|
|
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow and currently employs 575 full-time employees. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.141 - 2.152 |
2.152 - 2.161 |
|
Low:
|
1.936 - 1.947 |
1.947 - 1.955 |
|
Close:
|
2.003 - 2.021 |
2.021 - 2.035 |
|
Technical analysis |
as of: 2020-10-01 3:10:38 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 2.44 One year: 2.73 |
| Support: |
Support1: 1.68 Support2: 1.40 |
| Resistance: |
Resistance1: 2.09 Resistance2: 2.34 |
| Pivot: |
2.15 |
| Moving Average: |
MA(5): 2.04 MA(20): 2.13 
MA(100): 2.11 MA(250): 1.47 |
| MACD: |
MACD(12,26): -0.04 Signal(9): -0.02 |
| Stochastic oscillator: |
%K(14,3): 41.21 %D(3): 48.03 |
| RSI: |
RSI(14): 42.69 |
| 52-week: |
High: 3.28 Low: 0.56 Change(%): 77.5 |
| Average Vol(K): |
3-Month: 58500 10-Days: 18938 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.TRIB has closed above bottom band by 13.7%. Bollinger Bands are 35.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 15 Sep 2020
How Is Trinity Biotech's (NASDAQ:TRIB) CEO Paid Relative To Peers? - Yahoo Finance
Tue, 25 Aug 2020
Trinity Biotech Announces Results for Q2, 2020 Nasdaq:TRIB - GlobeNewswire
Thu, 20 Aug 2020
Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test - GlobeNewswire
Tue, 18 Aug 2020
Trinity Biotech plc to Announce Second Quarter 2020 Financial Results - GlobeNewswire
Mon, 17 Aug 2020
Trinity Biotech subsidiary, Primus Corporation Receives FDA Warning Letter - GlobeNewswire
Wed, 27 May 2020
Trinity Biotech Plc to Host Earnings Call - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
21 |
| Shares Float (M) |
14 |
|
% Held by Insiders
|
18.25 |
|
% Held by Institutions
|
44.40 |
|
Shares Short (K)
|
137 |
|
Shares Short P. Month (K)
|
564 |
Stock Financials |
|
EPS
|
-1.304 |
|
EPS Est This Year
|
0.270 |
|
EPS Est Next Year
|
0.330 |
|
Book Value (p.s.)
|
-0.030 |
|
Profit Margin
|
-32.47 |
|
Operating Margin
|
-0.18 |
|
Return on Assets (ttm)
|
-0.1 |
|
Return on Equity (ttm)
|
-141.1 |
|
Qtrly Rev. Growth
|
-28.8 |
|
Gross Profit (p.s.)
|
1.824 |
|
Sales Per Share
|
3.977 |
|
EBITDA (p.s.)
|
0.186 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
5 |
|
Levered Free Cash Flow (M)
|
-3 |
Stock Valuations |
|
PE Ratio
|
-1.51 |
|
PEG Ratio
|
|
|
Price to Book value
|
-65.67 |
|
Price to Sales
|
0.50 |
|
Price to Cash Flow
|
8.14 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2015-06-30 |
|
Ex-Dividend Date
|
2015-06-04 |
|
7 Binary Options
|
|
Your Ad Here
|
|
